Last updated on Jun 16, 2026
Get the free Quality Information Summary for Pharmaceutical Products
We are not affiliated with any brand or entity on this form
Fill out
Complete the form online in a simple drag-and-drop editor.
eSign
Add your legally binding signature or send the form for signing.
Share
Share the form via a link, letting anyone fill it out from any device.
Export
Download, print, email, or move the form to your cloud storage.
Why pdfFiller is the best tool for your documents and forms
End-to-end document management
From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.
Accessible from anywhere
pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.
Secure and compliant
pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.
What is QIS Form
The Quality Information Summary for Pharmaceutical Products is a healthcare form used by applicants and FPP manufacturers in Tanzania to provide a summary of key quality information for pharmaceutical product dossiers.
pdfFiller scores top ratings on review platforms
Who needs QIS Form?
Explore how professionals across industries use pdfFiller.
QIS Form is needed by:
-
Pharmaceutical product applicants
-
Qualified Persons in FPP manufacturing
-
Regulatory compliance officers
-
Quality assurance professionals
-
GMP inspectors
-
Healthcare providers in Tanzania
-
API manufacturers
Comprehensive Guide to QIS Form
What is the Quality Information Summary for Pharmaceutical Products?
The Quality Information Summary (QIS) form plays a crucial role in the Tanzanian pharmaceutical industry by providing a concise summary of essential information related to pharmaceutical products. This form is integral to compliance with Tanzania Medicines and Medical Devices Authority (TMDA) regulations, assisting regulatory bodies in inspections and evaluations.
The QIS form encompasses various types, including specifications for Active Pharmaceutical Ingredients (API) and Finished Pharmaceutical Products (FPP). By ensuring accurate documentation within this summary, pharmaceutical companies can adhere to the stringent guidelines set forth by TMDA.
Purpose and Benefits of the Quality Information Summary
The primary purpose of the Quality Information Summary is to streamline the pharmaceutical submission process. Utilizing the QIS form enhances efficiency during Good Manufacturing Practice (GMP) inspections and contributes to effective assessments.
This form significantly improves the clarity of quality information presented in product dossiers, making it easier for regulatory reviewers to analyze submissions. The TMDA QIS template assists applicants in organizing their information coherently, ensuring compliance and facilitating a smoother approval process.
Who Needs the Quality Information Summary for Pharmaceutical Products?
Multiple stakeholders require the Quality Information Summary to ensure the successful registration and evaluation of pharmaceutical products. Primarily, applicants must prepare and file the QIS form, while qualified persons in FPP manufacturing are responsible for providing specific information about their products.
Regulatory bodies also play an essential role in reviewing submissions using the QIS as a guiding document. Each party must understand their responsibilities to ensure accurate completion of the pharmaceutical dossier summary.
Key Features of the Quality Information Summary
The Quality Information Summary consists of critical components that must be accurately completed. Key sections include product information, administrative details, and essential API and FPP specifications.
Providing clear and detailed instructions for completion is vital, including notable signature requirements that must be followed to ensure the form's validity. These components are essential for creating a reliable and comprehensive QIS.
How to Fill Out the Quality Information Summary for Pharmaceutical Products (Step-by-Step)
-
Gather all necessary information, including API manufacturer details and specifications.
-
Complete each section of the form, ensuring that all required fields are filled in with accuracy.
-
Review the filled form thoroughly to confirm that all information is correct and complete.
Common Errors to Avoid When Submitting the Quality Information Summary
Avoiding common mistakes when completing the Quality Information Summary is crucial for successful submissions. Typical errors include incomplete sections or inaccurate data entry.
It is essential to review the form for any missing information before submission, ensuring compliance with TMDA standards. This proactive approach can minimize the risk of delays or rejections.
Security and Compliance Considerations for Submitting the Quality Information Summary
Data security and compliance are paramount when handling the Quality Information Summary. pdfFiller offers security features such as 256-bit encryption, assuring users that their information remains protected during submission.
Furthermore, compliance with regulations such as HIPAA and GDPR is necessary when submitting sensitive information. Adopting best practices for safeguarding data will enhance the overall submission experience.
How to Submit the Quality Information Summary for Pharmaceutical Products
Submitting the Quality Information Summary can be accomplished through various methods, including online platforms or in-person submissions. It's important to note any potential fees associated with the process as well as expected processing times.
Users should also track their submission status and use confirmation methods to ensure successful filing and acknowledgment from TMDA.
What Happens After You Submit the Quality Information Summary?
After the submission of the Quality Information Summary, applicants can anticipate specific timelines for receiving a response from TMDA. It is crucial to check the application status regularly for updates.
In the event of a rejection or the need for amendments, knowing the appropriate actions to take can help navigate the next steps effectively.
Leverage pdfFiller for Your Quality Information Summary Submission
Utilizing pdfFiller simplifies the process of filling out, signing, and submitting the Quality Information Summary. The platform allows users to create fillable forms and securely eSign documents, providing significant advantages for compliance and security.
Testimonials from users highlight the platform's efficiency and ease of use, emphasizing its value for anyone involved in the pharmaceutical submission process.
How to fill out the QIS Form
-
1.To access the Quality Information Summary form on pdfFiller, visit the pdfFiller website and use the search function to locate the form by its name or keywords.
-
2.Once you have found the form, click on it to open in the pdfFiller interface. Ensure you are logged in to your account to enable full editing capabilities.
-
3.Before filling out the form, gather all necessary information including details about the Active Pharmaceutical Ingredient (API), the manufacturer, and product specifications.
-
4.Navigate through the form using the toolbar on the left, and fill out required fields such as 'Name of API', 'Name of API manufacturer', and 'FPP manufacturer Qualified person's contact details'.
-
5.Follow any additional instructions that appear within the form, ensuring each section is completed accurately. Use the text boxes and drop-down menus provided.
-
6.Once you have completed all necessary sections, review the form for any errors or missing information. Utilize the print preview option to see how it will look when printed.
-
7.After finalizing your entries, save your work by clicking the save button at the top. You can choose to download the form as a PDF or submit it directly if applicable through the platform.
Who is eligible to use the Quality Information Summary form?
The form is primarily for pharmaceutical product applicants and Qualified Persons within FPP manufacturing in Tanzania. It is crucial for those responsible for providing quality information for product dossiers.
What is the deadline for submitting the Quality Information Summary?
Although specific deadlines may vary, it is recommended to submit the form well in advance of any regulatory review or GMP inspection dates to ensure compliance with the Tanzania Medicines Authority.
How should I submit the completed Quality Information Summary form?
The completed form can be submitted electronically through pdfFiller if applicable. Alternatively, you can download and print the form to submit it physically to the Tanzania Medicines and Medical Devices Authority.
What supporting documents are required when filing this form?
Typically, supporting documents include the product registration details, stability data, and quality specifications of the API and FPP. Always check for specific requirements from the TMDA.
What common mistakes should I avoid when completing this form?
Common mistakes include missing required fields, using incorrect product details, and failing to review the form before submission. Ensure all sections are correctly filled out and verify the information provided.
What are the processing times for submissions of this form?
Processing times can vary based on the TMDA's workload and the nature of the submission. It's advisable to check their website for any updates on processing times post-submission.
Are there any fees associated with submitting the Quality Information Summary?
Fees may be applicable based on the type of submission and regulatory requirements set by the TMDA. Always verify any potential fees prior to submission.
Related Forms
Get the latest insights from our blog
If you believe that this page should be taken down, please follow our DMCA take down process
here
.
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.